« Back to Record
Citation APA

Asselah, T., Lenz, O., Van Dooren, G., Nalpas, C., Lonjon-Domanec, I., Schlag, M., Buti, M., Moreno, C., Sarrazin, C., Gschwantler, M., Foster, G. G., Craxí, A., Buggisch, P., Sanai, F., & Bicer, C. (2017). Efficacy of a 12-week simeprevir plus peginterferon/ribavirin (PR) regimen in treatment-naïve patients with hepatitis C virus (HCV) genotype 4 (GT4) infection and mild-to-moderate fibrosis displaying early on-treatment virologic response. PloS one, 12(1), e0168713. doi:10.1371/journal.pone.0168713


Permalink

http://hdl.handle.net/2013/ULB-DIPOT:oai:dipot.ulb.ac.be:2013/247723

Asselah, T., Lenz, O., Van Dooren, G., Nalpas, C., Lonjon-Domanec, I., Schlag, M., Buti, M., Moreno, C., Sarrazin, C., Gschwantler, M., Foster, G. G., Craxí, A., Buggisch, P., Sanai, F., & Bicer, C. (2017). Efficacy of a 12-week simeprevir plus peginterferon/ribavirin (PR) regimen in treatment-naïve patients with hepatitis C virus (HCV) genotype 4 (GT4) infection and mild-to-moderate fibrosis displaying early on-treatment virologic response. PloS one, 12(1), e0168713. doi:10.1371/journal.pone.0168713